Proactively driving demand and business promotion through strategic technical sales. Developing marketing tools for enhanced product visibility. Leading post-marketing trials and identifying technical gaps for continuous improvement. Building and maintaining connections with diverse stakeholders. Actively pursuing new business and identifying product licensing opportunities. Key contributor to comprehensive commercial plans and overseeing marketing strategy implementation

Established Europe affiliate (October 2021) and key technical role in post-acquisition of hormone portfolio from HIPRA. Conducted sales analysis, evaluated portfolios, and devised a strategic plan for EMEA and Asia.Key contributions: Identified B2B distributors, proposed a product naming strategy, and addressed technical gaps. Solely shaped affiliate technical positioning, developed key products marketing plan, and created presentations, brochures, and website content.Initiated impactful activities: Outsourced solutions in Europe, developed a value proposition in Mexico, and organized a regulatory/technical seminar in Latam. Pioneered an innovative project, successfully launching in Brazil and Argentina. Responded to an FMD emergency in Indonesia, facilitating a partnership that resulted in sales exceeding 5 million doses of FMD vaccines.

Report directly to Asia & MENA Director. Drive B2B market expansion, focusing on strategic partner selection and business opportunities. Specialize in aligning key product portfolio with market needs, particularly for dairy cattle and small ruminants. Responsible for upgrading and developing value propositions.Oversee products, projects, and post-marketing clinical trials in MENA. Advise ongoing projects in APAC, searching for partners in a local hormone project in China and evaluating acquisition opportunities. Outsource complementary products in China for MENA, Asia, and LATAM markets, including PPR and POX vaccines, as well as progestin-based products for synchronization like sponges and silicone inserts.

Responsible for all technical aspects about products and projects in Asia and the Middle East (ME), focused on Animal Health (swine and ruminants – cattle, sheep and goats). Mainly focused on FMD vaccines, Rabies vaccine, hormones (swine and ruminants), and pharmaceuticals.Actively involved in business development in new markets in Asia and ME, with tight communication with commercial management. Broad networking.Leading the technical service team for Asia and ME. Responsible for training a cross-cultural team with different backgrounds.Responsible for training the technical and sales forces of distributors.Responsible for identifying and developing marketing tools for local application based on market needs, leading the link with HQ.Responsible for all activities to provide technical background for current claims or developing new ones. Involved in the process of developing and implement a marketing plan for product launching.Oral presentations in local and international events and congresses for the livestock industry (swine and ruminants).

- Project Management. Research, Development, and Innovation in Biotechnology of Animal Reproduction area. New products and New procedures.- Linkage with government and academic institutions, national and international, for the development and advancement of projects.- Development of technical and scientific information for animal reproduction range products. Responsible for scientific, national and international publications in Animal Reproduction area.- Linkage with the technical and commercial teams of the different subsidiaries. Transfer of scientific and technical information to them.-Argentina, Brazil, and Uruguay.

- Close contact with Research and Development and Regulatory Affairs.- Active participation (scientific information review, experimental design, and execution) in Clinical Studies: efficacy, residues (tissues and milk), pharmacokinetics, TAS (Target Animal Safety), clinical safety and clinical tolerance. All of those executed for hormonal, pharmaceutical and biological products (including FMD vaccine ), in different phases of development or in the registration process or even commercial products (marketing studies).- Direct responsible for the Clinical Studies related to Animal Reproduction: scientific information review, experimental design, execution, and statistical analysis of results.- Work developed under processes: SOP (Standard Operating Procedure), good practices of registration and Quality Control. In addition, GCP (Good Clinical Practices), and international Harmonization regulations and guidelines (VICH, EMEA, and FDA) and also national (Prosaia).

- Attending for more than 65.000 beef cattle in Argentina and another 20.000 in Bolivia.- Pregnant diagnosis and FTAI (Fix Timed Artificial Insemination) programmes. - Organizing and executing early weaning programmes in beef calves.